CASP9 and cancer: Isothiocyanate (ITC) molecules are promising anticancer agents that express elevated mitochondria targeting, leading to ITC-induced apoptotic cell death by activating the caspase-9-related apoptotic pathway and by regulating Bcl-2 protein family members related to pro-apoptotic signaling in cancer cells.